The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often follows surgery or injuries.
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
Trump indicated the 25% rate could represent a floor, saying that the tariff levels 'may or may not rise with time.” ...
The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...
The drug, Journavx, from Vertex Pharmaceuticals, reduced pain after surgery in clinical trials. Experts hope it can lead to fewer opioid prescriptions.
The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive. The Food and Drug ...
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller ...
This milestone marks a breakthrough after unsuccessful attempts to develop painkillers without the addictive potential of opioids.
A new pain relief drug, suzetrigine, is a prescription pill that’s taken every 12 hours after a larger starter dose. It will be sold under the brand name Journavx.
After two recent incidents caused several staff and inmates to be sent to the hospital, the state has locked down Upstate Correctional Facility in Malone. “For the safety of the staff, incarcerated ...
A BMW driver who killed a baby while high on a cocktail of drugs in a hit-and-run in Sevilla has been sent to jail for three years. The tragic incident ...
Following what New York state corrections officers say is a surge in incidents in which prison staff have fallen ill after ...